BETA: Please send your feedback!
Addex Therapeutics
ADXN-CH:SWX
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2002
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
website
Headquarters
Executives
Name | Title | Gender |
Vincent Mutel, PhD | Founder | Male |
Timothy Dyer | Chief Executive Officer | Male |
Mark s Epping-Jordan, PhD | Founder | Male |
Vincent M. Lawton, PhD | Chairman | Male |
Roger G. Mills, MD | Chief Medical Officer | Male |
Sonia Maria Poli, PhD | Chief Scientific Officer | Female |
Mindful Investing Summary
Addex Therapeutics - Competitors and Related Companies
How Addex Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Addex Therapeutics
ADXN-CH:SWX
Biotechnology
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…